International Aids Vaccine Initiative Inc.
New York, NY Doing business as International Aids Vaccine Initiative Inc.
- UEI
- ZEJBC8JQM3P5
- CAGE
- 44YM6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
International Aids Vaccine Initiative Inc.
ZEJBC8JQM3P5
- Iavi Africa LIMITED PQ84Z4K6YV79
-
International Aids Vaccine Initiative Inc.
ZEJBC8JQM3P5
- SAM.gov registration date
- Physical address
- 125 Broad St Fl 9, New York, NY 10004, USA
- Website
- iavi.org
- Founded
- 1996
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health & Wellness
- SIC code
- 83 Social Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About International Aids Vaccine Initiative Inc.
The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI provides a range of research, development, manufacturing, and advocacy services to advance the creation and delivery of vaccines and antibodies to prevent infectious diseases worldwide.
Through prime and subcontract awards from federal agencies like the National Institutes of Health (NIH), IAVI has provided preclinical and analytical services to support vaccine development for HIV, tuberculosis, influenza, Ebola, and other infectious diseases. Services include process development, analytical testing, manufacturing, toxicology studies, regulatory support, and clinical trial material production. IAVI serves as the prime contractor on many awards, partnering with subcontractors like universities, biotechnology companies, and research institutes to provide specialized expertise. The majority of IAVI's contract work has been funded by NIH institutes like NIAID and NCI, as well as BARDA, to advance promising vaccine candidates through preclinical and clinical testing. Most awards have not had set-aside designations.
Through prime and subawards from federal grant programs at agencies like NIH and USAID, IAVI has conducted research to develop novel HIV and tuberculosis vaccine candidates using cutting-edge platforms like mRNA. Additionally, IAVI has been funded to organize scientific conferences, provide technical assistance and business guidance to product developers, conduct health economics evaluations, and support advocacy efforts around HIV prevention research and domestic resource mobilization. As a subawardee, IAVI has contributed expertise in immunology, manufacturing, regulatory affairs, and clinical trial planning to multi-institution research consortia overseen by prime grantee organizations.
IAVI holds multiple indefinite delivery/indefinite quantity (IDIQ) contracts with NIH, including vehicles with NIAID for preclinical services supporting biopharmaceutical product development and preclinical/translational vaccine development for HIV and other infectious diseases. Under these IDIQs, IAVI provides a comprehensive suite of services across all stages of the product development lifecycle through multi-year task order awards. Services include product development planning, analytical testing, process and assay development, cGMP manufacturing, regulatory support, and storage/logistics. Federal agencies can issue task orders against these IDIQs to advance promising vaccines, therapeutics, and diagnostics towards clinical trials and licensure.
Contract vehicles
Quick answers
What is International Aids Vaccine Initiative Inc.'s UEI?
International Aids Vaccine Initiative Inc.'s Unique Entity ID (UEI) in SAM.gov is ZEJBC8JQM3P5.
What is International Aids Vaccine Initiative Inc.'s CAGE code?
International Aids Vaccine Initiative Inc.'s CAGE code is 44YM6.
What is International Aids Vaccine Initiative Inc.'s primary NAICS code?
International Aids Vaccine Initiative Inc.'s primary NAICS code is 541720 (Research and Development in the Social Sciences and Humanities).
Where is International Aids Vaccine Initiative Inc. located?
International Aids Vaccine Initiative Inc.'s physical address in SAM.gov is 125 Broad St Fl 9, New York, NY 10004, USA.
Is International Aids Vaccine Initiative Inc. registered in SAM.gov?
Yes. International Aids Vaccine Initiative Inc.'s SAM.gov registration is active through November 4, 2026.
Which contract vehicles does International Aids Vaccine Initiative Inc. hold?
International Aids Vaccine Initiative Inc. holds a place on 2 federal contract vehicles, including Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
What is International Aids Vaccine Initiative Inc.'s most recent federal award?
International Aids Vaccine Initiative Inc.'s most recent federal contract award is Contract HHSN272201800010I international aids vaccine initiative manufacture of influenza virus human challenge material… (75N93023F00001), from National Institute of Allergy and Infectious Diseases, on September 26, 2023.
On GovTribe
See International Aids Vaccine Initiative Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors